HLA-A*0201 POSITIVE CELLS PRESENT

Clinical trials for HLA-A*0201 POSITIVE CELLS PRESENT explained in plain language.

Never miss a new study

Get alerted when new HLA-A*0201 POSITIVE CELLS PRESENT trials appear

Sign up with your email to follow new studies for HLA-A*0201 POSITIVE CELLS PRESENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New targeted therapy trial offers hope for rare, aggressive cancer

Disease control Recruiting now

This study is testing an immunotherapy drug called tebentafusp in people with advanced clear cell sarcoma, a rare and aggressive cancer. The trial is for patients who have a specific genetic marker (HLA-A*02:01) and whose cancer cannot be removed by surgery or has spread. Partici…

Matched conditions: HLA-A*0201 POSITIVE CELLS PRESENT

Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

HLA-A*0201 POSITIVE CELLS PRESENT

Get alerted when new HLA-A*0201 POSITIVE CELLS PRESENT trials appear

New targeted therapy trial offers hope for rare, aggressive cancer